𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential expression of insulin-like growth factor binding proteins in murine hematopoietic stromal cell lines

✍ Scribed by Teresa F. Clawson; Wei-Hua Lee; Mervin C. Yoder


Book ID
116122805
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
870 KB
Volume
120
Category
Article
ISSN
0303-7207

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Expression of insulin-like growth factor
✍ Jung H. Y. Park; Mark R. Corkins; Jon A. Vanderhoof; Nia M. Caruso; Marjorie J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 790 KB

differentiation is linked to growth of Caco-2 cells, with markers of functional differentiation increasing only after the cells stop proliferating (Pinto e t al., 1983). Given these limitations, Caco-2 cells appear to represent the most relevant in vitro model currently available for study of prolif

Differential expression of insulin-like
✍ Jiangming Luo; Liam J. Murphy πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 682 KB

Multiple factors contribute to the growth retardation which is a characteristic feature of uncontrolled diabetes. In this report we have examined the effects of streptozotocin-induced (STZ) diabetes on expression of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-

Insulin-like growth-factor-binding prote
✍ Julie G. Reeve; Lemuel B. Kirby; Ad Brinkman; Stephanie A. Hughes; Jurg Schwande πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 828 KB

The secretion of insulin-like growth-factor-binding proteins (IGFBPs) and expression of the genes encoding IGFBP-I, IGFBP-2 and IGFBP-3 have been studied in a panel of cell lines derived from breast carcinomas, Wilms' tumour, neuroblastoma, retinoblastoma, colon carcinoma, liver adenocarcinoma, Burk

Expression of insulin-like growth factor
✍ Linda A. Dahlgren; Hussni O. Mohammed; Alan J. Nixon πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 223 KB

## Abstract The treatment of overuse tendon injuries with exogenous growth factors such as insulin‐like growth factor‐I (IGF‐I) may facilitate an improved return to sustained athletic function. The biological effects of IGF‐I are exerted under the control of a complex of IGF receptors, binding prot